BACE New Technology Showcase: Cardea Bio

In the next BACE event we will cross the boundaries between biology and electronics, following the lead of Cardea Bio - the first company integrating biologics with graphene semiconductors to create BPUs™ - Biosignal Processing Units. Join us to learn about the plethora of potential applications of BPUs in multiomics, liquid biopsy, and molecular assays. And hear from CRISPR QC - the company using BPU-based CRISPR-Chip to help optimize CRIPSR editing for gene therapy, cell therapy and other applications.

Agenda:

4:00 pm Welcome!

4:05 pm “From CPUs to BPUs: Next-Generation Transistors for Amplification-Free Genotyping” Dr. Francie Barron, VP Innovation Partnership, Cardea Bio

4:35 pm “Incorporating CRISPR QC check points to improve CRISPR designs” Ken Dickerson, CRISPR Group Leader, CRISPR QC

5:05 pm Q&A and discussion

5:30 pm Event ends